Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial.

Translated title of the contribution: Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial.

M.H.J. van Oers, R. Klasa, R.E. Marcus, M. Wolf, E. Kimby, R.D. Gascoyne, A. Jack, M.B. van 't Veer, A. Vranovsky, H. Holte, M. van Glabbeke, I. Teodorovic, C. Roczewicz, A. Hagenbeek

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionRituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial.
Original languageUndefined/Unknown
Pages (from-to)3295-3301
Number of pages7
JournalBlood
Volume108
Issue number10
Publication statusPublished - 2006

Cite this